Clinical symptoms of urinary tract infection (including prostatitis) at the time of enrollment.

History of prostate cancer.

History of invasive treatments for benign prostatic hypertrophy (BPH) or lower urinary track symptoms within 6 months of study enrollment.

Known hepatitis status (all types) and/or HIV documented in patient's medical record.

Patients with history of concurrent renal/bladder tumors.

Prior MRI used in the decision to biopsy

Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy